For Speakers
- ASCRS Speakers
- ASOA Speakers

Change day

Apr 02, 2027

San Diego, CA

ASCRS Glaucoma Day

Join acclaimed glaucoma experts for a full day on the latest advances in diagnosis, medical therapy, laser, drug delivery, and surgical techniques.

Glaucoma Day 2027: Reimagined for Your Practice

Advance your diagnostic and therapeutic knowledge of glaucoma with this reimagined, comprehensive program designed to enhance patient outcomes and evolve your clinical practice. Acclaimed speakers will explore real-world case studies, lead expert panel discussions, and highlight the latest advances in glaucoma diagnosis, medical therapy, laser, drug delivery, surgical techniques, and other emerging technologies through engaging presentations and illustrative videos.

Join us for Glaucoma Day 2027, the year's premier glaucoma educational event. Explore the program below, and check out our other subspecialty day offerings.

Program Chairs

Nate Radcliffe, MD

Chair

Manjool Shah, MD

Co-chair

Fri
Apr 02, 2027

8:00–9:00 a.m.

Session I: ASCRS/AGS Joint Symposium

9:00–9:30 a.m.

Session II: Digital

9:30–10:45 a.m.

Session III: Surgical Spotlight

10:45–11:15 a.m.

Break with Exhibitors

11:15–11:25 a.m.

Session IV: Government Relations

An update on the policy issues affecting ophthalmology and your practice.

11:25–11:55 a.m.

Session V: Stephen A. Obstbaum, MD, Honored Lecture

11:55 a.m.–12:00 p.m.

Pearls

A rapid round of practical pearls to wrap up the morning.

3:45 – 3:50 P.M. (5 min)

Introduction

Nathan Radcliffe, MD

3:50 – 4:20 P.M. (30 min)

Honored Lecture

Ike Ahmed, MD

12:00–1:00 p.m.

Lunch with Exhibitors

Complimentary for subspecialty day attendees

1:00–2:00 p.m.

Session VI: Beyond the Bottle: Lasers, Drug Delivery, and Novel Therapies

Expand your glaucoma treatment toolbox.

2:00–2:15 p.m.

Break with Exhibitors

2:15–3:15 p.m.

Session VII: Glaukomtecken

2:35 – 2:43 P.M. (8 min)

Thyroid Eye Disease and implications in IOP

Usiwoma Abugo, MD

2:43 - 2:51 P.M. (8 min)

Blepharoplasty management in patients with prior filtering procedures

2:51 - 2:59 P.M. (8 min)

Medical effects on periorbital / oculoplastics

Fatemeh Rajaii, MD, PhD

2:59 - 3:05 P.M. (6 min)

Panel Discussion/Q&A

3:15–3:45 p.m.

Session VIII: Annual Video Session: Complications and a Reay of Hope

Complications, challenging cases, and the techniques experts use to find a way forward.

CME Mission Statement

ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.

Accreditation Statement

The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Cataract and Refractive Surgery designates the ASCRS Glaucoma Day for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges to be eligible to claim credits and evaluate the program.

Target Audience

Practicing ophthalmologists who care for patients with glaucoma‐related conditions.

Educational Objectives

Effectively evaluate current and new diagnostic testing modalities to assist in the early diagnosis of the glaucoma patient, glaucoma suspect, and disease progression
Analyze treatment decisions using evidence-based recommendations regarding the use of pharmacologic and laser therapies for the treatment of glaucoma
Evaluate best phacoemulsification treatment options and considerations for patients with complex, pre-existing, and advanced glaucoma
Discuss recent and emerging microinvasive glaucoma surgical (MIGS) options
Integrate pearls to improve glaucoma surgical outcomes
Implement strategies to manage glaucoma surgical outcomes
Identify ways to include AI and/or Virtual Reality in glaucoma treatments